Navigation Links
Treatment with fungi makes a modern violin sound like a Stradiavarius
Date:9/7/2012

A good violin depends not only on the expertise of the violin maker, but also on the quality of the wood that is used. The Swiss wood researcher Professor Francis W. M. R. Schwarze (Empa, Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland) has succeeded in modifying the wood for a violin through treatment with special fungi. This treatment alters the acoustic properties of the instrument, making it sound indistinguishably similar to a Stradivarius. In his dinner talk at the 1st ECRC "Franz-Volhard" Symposium of the Max Delbrck Center for Molecular Medicine (MDC) and Charit - Universittsmedizin on September 7, 2012 in Berlin-Buch, Schwarze reported on his research and gave a preview of what his wood treatment method could mean, particularly for young violinists.

Low density, high speed of sound and a high modulus of elasticity these qualities are essential for ideal violin tone wood. In the late 17th and early 18th century the famous violin maker Antonio Stradivari used a special wood that had grown in the cold period between 1645 and 1715. In the long winters and the cool summers, the wood grew especially slowly and evenly, creating low density and a high modulus of elasticity. Until now, modern violin makers could only dream of wood with such tonal qualities.

Professor Schwarze's developments could soon make similarly good wood available for violin making. He discovered two species of fungi (Physisporinus vitreus and Xylaria longipes), which decay Norway spruce and sycamore the two important kinds of wood used for violin making to such an extent that their tonal quality is improved. "Normally fungi reduce the density of the wood, but at the same time they unfortunately reduce the speed with which the sound waves travel through the wood," the researcher explained. "The unique feature of these fungi is that they gradually degrade the cell walls, thus inducing a thinning of the walls. But even in the late stages of the wood decomposition, a stiff scaffold structure remains via which the sound waves can still travel directly." Even the modulus of elasticity is not compromised; the wood remains just as resistant to strain as before the fungal treatment an important criterion for violin making. Before the wood is further processed to a violin, it is treated with ethylene oxide gas. "No fungus can survive that," Professor Schwarze said. That ensures that fungal growth in the wood of the violin is completely stopped.

Together with the violin makers Martin Schleske and Michael Rhonheimer, Professor Schwarze developed violins made of mycowood (wood treated with wood decay fungi). In 2009 the violins were played in a blind, behind-the-curtain test versus a genuine Stradivarius from 1711. All the violins were played by the British violinist Matthew Trusler. The result was surprising for all participants: Both the jury of experts and the majority of the audience thought that the mycowood violin that Schwarze had treated with fungi for nine months was the actual Strad. "Of course, such a test is always subjective," Professor Schwarze said. "There is no clear-cut, scientific method for measuring tonal quality."

Currently Professor Schwarze is working on an interdisciplinary project to develop a quality-controlled treatment for violin wood, with successful, reliable and reproducible results. Until 2014, within the scope of the project that is funded by the Swiss Walter Fischli Foundation, 30 additional violins shall be made from fungally-treated wood. Schwarze explained what opportunities this project can lead to: "The successful implementation of biotechnological methods for treating soundboard wood could in the future give young musicians the opportunity to play on a violin with the sound quality of an expensive and for most musicians unaffordable Stradivarius."


'/>"/>
Contact: Bachtler, Barbara
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Related biology news :

1. HIV treatment use increases in the US
2. Lyme retreatment guidance may be flawed
3. WSU/USDA scientist creates test, treatment for malaria-like sickness in horses
4. RI Hospital: Use of PMP may increase demand for drug treatment, reduce painkiller abuse
5. Gene discovery could improve treatment for acute myeloid leukemia
6. Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma?
7. Powerful class of antioxidants may be potent Parkinsons treatment
8. ECGs administered by paramedics can speed treatment for severe heart attacks
9. Reorganizing brain could lead to new stroke, tinnitus treatments
10. OHSU discovery may lead to new treatment for ALS
11. Real-life spider men using protein found in venom to develop muscular dystrophy treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
Breaking Biology Technology: